DAWN
Price
$6.45
Change
-$0.31 (-4.59%)
Updated
May 9 closing price
Capitalization
653.79M
92 days until earnings call
SMMT
Price
$23.96
Change
-$0.69 (-2.80%)
Updated
May 9 closing price
Capitalization
17.79B
87 days until earnings call
Ad is loading...

DAWN vs SMMT

Header iconDAWN vs SMMT Comparison
Open Charts DAWN vs SMMTBanner chart's image
Day One Biopharmaceuticals
Price$6.45
Change-$0.31 (-4.59%)
Volume$1.34M
Capitalization653.79M
Summit Therapeutics
Price$23.96
Change-$0.69 (-2.80%)
Volume$2.53M
Capitalization17.79B
DAWN vs SMMT Comparison Chart
Loading...
DAWN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SMMT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DAWN vs. SMMT commentary
May 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DAWN is a Buy and SMMT is a Buy.

Ad is loading...
COMPARISON
Comparison
May 12, 2025
Stock price -- (DAWN: $6.45 vs. SMMT: $23.96)
Brand notoriety: DAWN and SMMT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DAWN: 106% vs. SMMT: 58%
Market capitalization -- DAWN: $653.79M vs. SMMT: $17.79B
DAWN [@Biotechnology] is valued at $653.79M. SMMT’s [@Biotechnology] market capitalization is $17.79B. The market cap for tickers in the [@Biotechnology] industry ranges from $296.96B to $0. The average market capitalization across the [@Biotechnology] industry is $2.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DAWN’s FA Score shows that 0 FA rating(s) are green whileSMMT’s FA Score has 2 green FA rating(s).

  • DAWN’s FA Score: 0 green, 5 red.
  • SMMT’s FA Score: 2 green, 3 red.
According to our system of comparison, SMMT is a better buy in the long-term than DAWN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DAWN’s TA Score shows that 4 TA indicator(s) are bullish while SMMT’s TA Score has 5 bullish TA indicator(s).

  • DAWN’s TA Score: 4 bullish, 4 bearish.
  • SMMT’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, SMMT is a better buy in the short-term than DAWN.

Price Growth

DAWN (@Biotechnology) experienced а -18.66% price change this week, while SMMT (@Biotechnology) price change was -14.12% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.25%. For the same industry, the average monthly price growth was +9.40%, and the average quarterly price growth was -13.49%.

Reported Earning Dates

DAWN is expected to report earnings on Aug 12, 2025.

SMMT is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (-6.25% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SMMT($17.8B) has a higher market cap than DAWN($654M). SMMT YTD gains are higher at: 34.267 vs. DAWN (-49.092). SMMT (-212.51M) and DAWN (-215.24M) have comparable annual earnings (EBITDA) . DAWN has more cash in the bank: 532M vs. SMMT (412M). DAWN has less debt than SMMT: DAWN (2.6M) vs SMMT (7.22M). DAWN has higher revenues than SMMT: DAWN (131M) vs SMMT (0).
DAWNSMMTDAWN / SMMT
Capitalization654M17.8B4%
EBITDA-215.24M-212.51M101%
Gain YTD-49.09234.267-143%
P/E RatioN/A26.41-
Revenue131M0-
Total Cash532M412M129%
Total Debt2.6M7.22M36%
FUNDAMENTALS RATINGS
SMMT: Fundamental Ratings
SMMT
OUTLOOK RATING
1..100
40
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
PROFIT vs RISK RATING
1..100
30
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
7
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
DAWNSMMT
RSI
ODDS (%)
Bullish Trend 3 days ago
89%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 3 days ago
87%
Momentum
ODDS (%)
Bearish Trend 3 days ago
83%
Bullish Trend 3 days ago
86%
MACD
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 3 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
82%
Bullish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 18 days ago
80%
Bullish Trend 4 days ago
85%
Declines
ODDS (%)
Bearish Trend 5 days ago
82%
Bearish Trend 26 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
83%
Bearish Trend 3 days ago
80%
Aroon
ODDS (%)
Bearish Trend 3 days ago
85%
N/A
View a ticker or compare two or three
Ad is loading...
DAWN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SMMT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSLA298.2613.44
+4.72%
Tesla
GME27.540.76
+2.84%
GameStop Corp
BTC.X104696.3300001725.468800
+1.68%
Bitcoin cryptocurrency
AAPL198.531.04
+0.53%
Apple
SPY564.34-0.72
-0.13%
SPDR® S&P 500® ETF

DAWN and

Correlation & Price change

A.I.dvisor indicates that over the last year, DAWN has been loosely correlated with OCUL. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if DAWN jumps, then OCUL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DAWN
1D Price
Change %
DAWN100%
-4.59%
OCUL - DAWN
47%
Loosely correlated
-5.23%
RVMD - DAWN
47%
Loosely correlated
-3.56%
IDYA - DAWN
45%
Loosely correlated
-4.18%
DNLI - DAWN
45%
Loosely correlated
-0.42%
NRIX - DAWN
45%
Loosely correlated
-1.45%
More

SMMT and

Correlation & Price change

A.I.dvisor indicates that over the last year, SMMT has been closely correlated with BCDA. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if SMMT jumps, then BCDA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SMMT
1D Price
Change %
SMMT100%
-2.80%
BCDA - SMMT
69%
Closely correlated
N/A
BNTX - SMMT
42%
Loosely correlated
-2.12%
TIL - SMMT
36%
Loosely correlated
+1.53%
XERS - SMMT
35%
Loosely correlated
-2.91%
DAWN - SMMT
32%
Poorly correlated
-4.59%
More